- Home
- CTMX vs IH Comparison
CTMX vs IH Comparison
Compare CTMX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTMX | IH |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 116.0M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CTMX | IH |
|---|---|---|
| Price | $4.39 | $2.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 9.3K |
| Earning Date | 11-06-2025 | 12-19-2025 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | ★ 50.22 | N/A |
| EPS | 0.24 | ★ 0.29 |
| Revenue | $113,631,000.00 | ★ $123,215,612.00 |
| Revenue This Year | N/A | $39.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.32 | ★ $7.65 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $1.55 |
| 52 Week High | $4.62 | $3.60 |
Technical Indicators
Market Signals| Indicator | CTMX | IH |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 38.84 |
| Support Level | $3.86 | $2.15 |
| Resistance Level | $4.37 | $2.40 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 90.71 | 21.44 |
Price Performance
Historical ComparisonAbout CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.